Masimo (MASI) late Tuesday said Katie Szyman has been selected as the new chief executive officer at the medical device company, succeeding interim CEO Michelle Brennan, who was appointed to be the new chair of Masimo's board of directors.
Both moves take effect on Feb. 12, the company said.
Szyman currently is the worldwide president for advanced patient monitoring at Becton, Dickinson (BD) and previously led the critical care product group at Edwards Lifesciences before its acquisition by BD in September 2024.
Brennan temporarily became CEO at Masimo on Sept. 25 after Joe Kiani disclosed plans to step down from the company. The former Johnson & Johnson senior executive was elected to the Masimo board in 2023.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。